ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) — RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference.
RxSight® management is scheduled to present Thursday, January 13, 2022, at 6:45am PT / 9:45am ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com
BERWYN, Pa.--(BUSINESS WIRE)--Titan CEO and headline sponsor Wipfli LLP are pleased to announce Bill Oldham, chairman…
The FQHC leverages eClinicalWorks EDR and AI-powered medical scribe to reduce physician burnout and improve…
NEWBURY, England, June 13, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical…
Google executive brings more than two decades of financial and management expertise to medical technology…
Improving life sciences research, clinical studies and post-market surveillance powered by data and AI NEWTOWN,…
REDDING, Calif., June 13, 2024 /PRNewswire/ -- Meticulous Research®– a leading global market research company published…